A far-upstream AP-1/Smad binding box regulates human NOX4 promoter activation by transforming growth factor-β

Gene

Volumn 540, Issue 1, 2014, Pages 62-67

  Bai, Guangxing ^a   Hock, Thomas D ^a   Logsdon, Naomi ^a   Zhou, Yong ^a   Thannickal, Victor J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

NADPH Oxidase 4; Pulmonary fibrosis; TGF 1

Indexed keywords

AP 1 PROTEIN; DNA FRAGMENT; PROTEIN; PROTEIN C JUN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FIBROBLAST; GENE; GENE ACTIVATION; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NOX4 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UPREGULATION;

NADPH OXIDASE-4; PULMONARY FIBROSIS; TGF-Β1;

BASE SEQUENCE; BINDING SITES; CELL LINE; GENE EXPRESSION; HUMANS; NADPH OXIDASE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; RNA STABILITY; SMAD3 PROTEIN; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84895874347     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.02.026     Document Type: Article

References (42)

1. Ago T., Kuroda J., Pain J., Fu C., Li H., Sadoshima J. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circulation Research 2010, 106:1253-1264.
2. Aguirre J., Lambeth J.D. Nox enzymes from fungus to fly to fish and what they tell us about Nox function in mammals. Free Radical Biology & Medicine 2010, 49:1342-1353.
3. Aoyama T., et al. Nicotinamide adenine dinucleotide phosphate oxidase (nox) in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 2012, 56:2316-2327.
4. Barnes J.L., Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney International 2011, 79:944-956.
5. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007, 87:245-313.
6. Bergstrom R., et al. Transforming growth factor beta promotes complexes between Smad proteins and the CCCTC-binding factor on the H19 imprinting control region chromatin. The Journal of Biological Chemistry 2010, 285:19727-19737.
7. Bonello S., et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:755-761.
8. Boudreau H.E., Emerson S.U., Korzeniowska A., Jendrysik M.A., Leto T.L. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. Journal of Virology 2009, 83:12934-12946.
9. Carmona-Cuenca I., Herrera B., Ventura J.J., Roncero C., Fernandez M., Fabregat I. EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death. Journal of Cellular Physiology 2006, 207:322-330.
10. Carnesecchi S., et al. A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxidants & Redox Signaling 2011, 15:607-619.
11. Cheng G., Cao Z., Xu X., van Meir E.G., Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001, 269:131-140.
12. Craige S.M., et al. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 2011, 124:731-740.
13. Cucoranu I., et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circulation Research 2005, 97:900-907.
14. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
15. Diebold I., Petry A., Hess J., Gorlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Molecular Biology of the Cell 2010, 21:2087-2096.
16. Geiszt M., Leto T.L. The Nox family of NAD(P)H oxidases: host defense and beyond. The Journal of Biological Chemistry 2004, 279:51715-51718.
17. Geiszt M., Kopp J.B., Varnai P., Leto T.L. Identification of renox, an NAD(P)H oxidase in kidney. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:8010-8014.
18. Goettsch C., Goettsch W., Arsov A., Hofbauer L.C., Bornstein S.R., Morawietz H. Long-term cyclic strain downregulates endothelial Nox4. Antioxidants & Redox Signaling 2009, 11:2385-2397.
19. Goettsch C., et al. Arterial flow reduces oxidative stress via an antioxidant response element and Oct-1 binding site within the NADPH oxidase 4 promoter in endothelial cells. Basic Research in Cardiology 2011, 106:551-561.
20. Haurani M.J., Cifuentes M.E., Shepard A.D., Pagano P.J. Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension 2008, 52:143-149.
21. Hecker L., et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nature Medicine 2009, 15:1077-1081.
22. Hock T.D., Nick H.S., Agarwal A. Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription. The Biochemical Journal 2004, 383:209-218.
23. Jiang J.X., et al. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radical Biology & Medicine 2012, 53:289-296.
24. Katsuyama M., et al. Sp3 transcription factor is crucial for transcriptional activation of the human NOX4 gene. The FEBS Journal 2011, 278:964-972.
25. Kuroda J., Ago T., Matsushima S., Zhai P., Schneider M.D., Sadoshima J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15565-15570.
26. Lu X., Murphy T.C., Nanes M.S., Hart C.M. PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. American Journal of Physiology. Lung Cellular and Molecular Physiology 2010, 299:L559-566.
27. Manea A., Tanase L.I., Raicu M., Simionescu M. Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular biology 2010, 30:105-112.
28. Manea A., Tanase L.I., Raicu M., Simionescu M. Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochemical and Biophysical Research Communications 2010, 396:901-907.
29. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cellular Signalling 2006, 18:69-82.
30. Mittal M., et al. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circulation Research 2007, 101:258-267.
31. Nauseef W.M. Biological roles for the NOX family NADPH oxidases. The Journal of Biological Chemistry 2008, 283:16961-16965.
32. Pendyala S., et al. Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: identification of functional antioxidant response elements on the Nox4 promoter. Free Radical Biology & Medicine 2011, 50:1749-1759.
33. Pepe A.E., et al. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circulation Research 2010, 106:870-879.
34. Pierrat M.J., Marsaud V., Mauviel A., Javelaud D. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-beta. The Journal of Biological Chemistry 2012, 287:17996-18004.
35. Sampson N., et al. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Molecular Endocrinology 2011, 25:503-515.
36. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
37. Shiose A., et al. A novel superoxide-producing NAD(P)H oxidase in kidney. The Journal of Biological Chemistry 2001, 276:1417-1423.
38. Tobar N., Guerrero J., Smith P.C., Martinez J. NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration. British Journal of Cancer 2010, 103:1040-1047.
39. von Lohneysen K., Noack D., Jesaitis A.J., Dinauer M.C., Knaus U.G. Mutational analysis reveals distinct features of the Nox4-p22 phox complex. The Journal of Biological Chemistry 2008, 283:35273-35282.
40. von Lohneysen K., Noack D., Hayes P., Friedman J.S., Knaus U.G. Constitutive NADPH oxidase 4 activity resides in the composition of the B-loop and the penultimate C terminus. The Journal of Biological Chemistry 2012, 287:8737-8745.
41. White S.J., Hayes E.M., Lehoux S., Jeremy J.Y., Horrevoets A.J., Newby A.C. Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress. Journal of Cellular Physiology 2011, 226:2841-2848.
42. Zhang L., Sheppard O.R., Shah A.M., Brewer A.C. Positive regulation of the NADPH oxidase NOX4 promoter in vascular smooth muscle cells by E2F. Free Radical Biology & Medicine 2008, 45:679-685.